Does NAD+ supplementation slow biological aging?
NAD+ supplementation demonstrably raises NAD+ levels in humans and appears to be safe, but whether it slows biological ageing has not yet been shown in clinical research. Those who wish to try it can do so without known risks, but should not expect a proven anti-ageing effect.
NAD+ is a compound that plays a central role in cellular energy metabolism and in repair processes following DNA damage. Both animal research and a limited number of human studies point to a consistent picture: NAD+ levels decline with age. How pronounced that decline is in humans has not yet been mapped in detail, because available human tissue data are scarce1,2,3,4.
The most robust finding from clinical studies is that oral supplementation with NAD+ precursors, particularly nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN), reliably raises NAD+ concentrations in the blood and in multiple tissues in humans. That effect has been found consistently across several human studies3,5,4. NR and NMN also appear to be safe and well tolerated at the doses and study durations investigated so far; no serious adverse effects have been reported3,5.
The central question, whether higher NAD+ levels actually produce measurable improvements in health, remains unanswered. Clinical studies examining muscle strength, cognition and cardiovascular function show mixed results. Sample sizes are small, doses vary and study durations are short, making it impossible to draw firm conclusions about functional benefit in humans3,5,4.
Findings from mouse research are more encouraging. In a mouse model of Alzheimer's disease, NR supplementation reduced inflammatory processes in the brain, DNA damage and cellular ageing, and improved memory and synaptic function6. In other animal models, raising NAD+ improved multiple forms of heart disease, including heart failure and atherosclerosis, and extended healthy lifespan7. These are, however, animal studies, and translation to humans cannot be taken for granted.
Whether NAD+ supplementation actually slows biological ageing or extends healthy lifespan in humans has not been demonstrated at this time. No large, long-term clinical studies exist to show this. The available human data are insufficient to confirm the promising animal results4,3,5,2. For those considering NR or NMN: the supplements demonstrably raise NAD+ levels and appear to be safe, but whether that translates into a meaningful health benefit remains an open question at this point.
All claims are based on the supplied abstracts (PMID 24786309, 26785480, 34497121, 34843394, 37068054, 37619764, 41083806). The human clinical studies are consistent in showing that NR/NMN raises NAD+ levels, but they are small in design and short in duration. Animal studies are promising but have not been translated to humans. No large long-term RCTs or meta-analyses are available with biological ageing as an outcome.